查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606585

全球临床次世代定序仪（NGS）领域分​​析（2024-2030）

Analysis of the Clinical Next-generation Sequencing Sector, Global, 2024-2030
出版日期: | 出版商: Frost & Sullivan | 英文 71 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

对人工智慧的持续投资将加速资讯解决方案开发并推动变革性成长

Frost & Sullivan 的分析研究了临床次世代定序仪(NGS) 产业，涵盖不同类型的产品、工作流程和临床应用。全球市场预计将在 2024 年至 2030 年期间稳定成长，其中服务和资讯学领域是主要驱动力，实现重要的收益里程碑。 NGS 市场包括端到端工作流程，包括文库製备、定序以及资料分析和解释，专为製药/生物技术和诊断等关键最终用户领域的临床使用而设计。在这些领域，NGS技术主要用于疾病诊断和监测、伴同性诊断、临床试验和患者分层。

该分析评估了推动和限制 NGS 技术在临床实践中使用成长的因素，并提供了来自北美、欧洲、亚太地区 (APAC)、拉丁美洲以及中东、非洲和南亚 (MEASA) 的案例研究。 。它还透过评估行业细分、法规环境和新兴经营模式以及市场收益和预测，揭示了行业带来的核心成长机会。

目录

生态系统

  • 分析范围
  • 分割

成长环境：临床次世代定序仪的转型

  • 为什么成长如此困难？
  • The Strategic Imperative 8（TM）
  • 临床次世代定序仪产业三大策略挑战的影响

临床次世代定序仪生态系统

  • 竞争环境
  • 主要竞争对手

临床次世代定序仪中的成长要素

  • 成长指标
  • 生长促进因子
  • 成长抑制因素
  • 预测考虑因素
  • 收益预测
  • 按产品分類的收益预测
  • 按工作流程进行收益预测
  • 按用途分類的收益预测
  • 按地区分類的收益预测
  • 收益预测分析
  • 价格趋势和预测分析
  • 收益占有率
  • 收益占有率分析
  • 竞争者
  • 企业应用资讯学解决方案

成长要素：装备

  • 成长指标
  • 收益预测
  • 按地区分類的收益预测
  • 预测分析

成长要素：工作流程解决方案

  • 成长指标
  • 收益预测
  • 按地区分類的收益预测
  • 预测分析

成长要素：服务

  • 成长指标
  • 收益预测
  • 按地区分類的收益预测
  • 预测分析

成长要素：资讯学

  • 成长指标
  • 收益预测
  • 按地区分類的收益预测
  • 预测分析

临床次世代定序仪领域的成长机会领域分析

  • 成长机会 1：整合多组体学资料以实现个人化医疗
  • 增长机会2：癌症微小残留病灶的检测与治疗
  • 成长机会3：单细胞与空间体学在临床研究的扩展
  • 成长机会 4：亚太地区、中东、非洲和南亚的基因组学计画和生物资讯学发展

附录与后续步骤

  • 成长机会的好处和影响
  • 下一步
  • 附件清单
  • 免责声明
简介目录
Product Code: KAE6-55

Continued Investment in AI is Driving Transformational Growth by Accelerating Information Solutions Development

This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. The NGS market encompasses end-to-end workflows, including library preparation, sequencing, and data analysis and interpretation, specifically designed for clinical applications across key end-user segments: pharmaceutical and biotechnology, and diagnostics. Within these sectors, NGS technologies are primarily employed to diagnose and monitor diseases, as well as for companion diagnostics, clinical trials, and patient stratification.

This analysis assesses the factors driving and restraining the growth of the use of NGS technology in clinical settings and offers case studies from North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East, Africa, and South Asia (MEASA). It also identifies the core growth opportunities that the industry presents by evaluating industry segments, the regulatory environment, and emerging business models, as well as market revenue and forecasts.

Table of Contents

Ecosystem

  • Scope of Analysis
  • Segmentation

Growth Environment: Transformation in Clinical Next-generation Sequencing

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Clinical Next-generation Sequencing Industry

Ecosystem in Clinical Next-generation Sequencing

  • Competitive Environment
  • Key Competitors

Growth Generator in Clinical Next-generation Sequencing

  • Growth Metrics
  • Growth Drivers
  • Growth Restraints
  • Forecast Considerations
  • Revenue Forecast
  • Revenue Forecast by Product
  • Revenue Forecast by Workflow
  • Revenue Forecast by Application
  • Revenue Forecast by Region
  • Revenue Forecast Analysis
  • Pricing Trends and Forecast Analysis
  • Revenue Share
  • Revenue Share Analysis
  • Competitive Players
  • Company Informatics Solutions for Applications

Growth GeneratorInstruments

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth GeneratorWorkflow Solutions

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth GeneratorServices

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth GeneratorInformatics

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Opportunity Universe Analysis of the Clinical Next-generation Sequencing Sector

  • Growth Opportunity 1: Integration of Multi-omics Data for Personalized Medicine
  • Growth Opportunity 2: Minimal Residual Disease Detection and Treatment in Cancer
  • Growth Opportunity 3: Expansion of Single-cell and Spatial Omics in Clinical Research
  • Growth Opportunity 4: Genomics Initiatives and Bioinformatics Development in APAC and MEASA

Appendix & Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • List of Exhibits
  • Legal Disclaimer